Köhrer, Sebastian http://orcid.org/0000-0002-4046-8586
Dittrich, Tobias http://orcid.org/0000-0002-6442-8255
Schorb, Martin http://orcid.org/0000-0003-4910-1868
Weinhold, Niels http://orcid.org/0000-0002-5464-3234
Haberbosch, Isabella
Börmel, Mandy http://orcid.org/0000-0002-4354-891X
Pajor, Gabor
Goldschmidt, Hartmut
Müller-Tidow, Carsten
Raab, Marc S.
John, Lukas http://orcid.org/0000-0001-8178-6890
Seckinger, Anja
Brobeil, Alexander
Dreger, Peter http://orcid.org/0000-0002-7429-8570
Tornóczky, Tamás
Pajor, László
Hegenbart, Ute http://orcid.org/0000-0003-1917-6746
Schönland, Stefan O. http://orcid.org/0000-0002-4853-5579
Schwab, Yannick
Krämer, Alwin http://orcid.org/0000-0001-8232-9982
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KR 1981/4-1, HE 8472/1-1, SCHO 1364/2-1)
Physician Scientist Program, University of Heidelberg
Dietmar Hopp Stiftung
Article History
Received: 2 August 2023
Revised: 14 September 2023
Accepted: 29 September 2023
First Online: 11 October 2023
Competing interests
: NW received honoraria from Sanofi. HG has research funding from Amgen, BMS, Celgene, Chugai, Janssen, Incyte, Molecular Partners, Merck Sharp and Dohme, Sanofi, Mundipharma GmbH, Takeda, Dietmar-Hopp-Foundation, Johns Hopkins University, and Novartis; served as an advisor for Adaptive Biotechnology, Amgen, BMS, Celgene, Janssen, Sanofi, and Takeda; received honoraria from Amgen, BMS, Celgene, Chugai, GlaxoSmithKline, Janssen, Novartis, and Sanofi. CM-T served as a consultant for Janssen and received research funding from Bioline, Pfizer, and Janssen. MSR received research funding from Amgen, Sanofi, Novartis, and Heidelberg Pharma; served as a consultant for Amgen, Sanofi, Novartis, BMS, Janssen, AbbVie, Regeneron, Takeda, and GSK. LJ served as an advisor for Janssen. PD is a paid consultant for AbbVie, AstraZeneca, Bluebird Bio, Gilead, Janssen, Novartis, Riemser, and Roche; is affiliated with AbbVie, AstraZeneca, Gilead, Novartis, Riemser, and Roche speakers bureaus; receives research support from Riemser. UH received travel grants from Janssen, Prothena, and Pfizer; served on advisory boards for Pfizer, Janssen and Prothena; received honoraria from Janssen, Pfizer, Alnylam, and Akcea, and received research funding from Janssen and Prothena. AK received honoraria from Hoffmann-La Roche, Bayer, Daiichi Sankyo, and AbbVie, and research funding from Bayer and Merck; is a paid consultant for Hoffmann-La Roche, Daiichi Sankyo, Bristol Myers Squibb, and AbbVie. The other authors declare no competing interests.